Overview

A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of an anticholinergic drug treatment administered by transdermal patch to treat overactive bladder in adults who have spinal cord injury.
Phase:
Phase 4
Details
Lead Sponsor:
Watson Pharmaceuticals
Treatments:
Mandelic Acids
Oxybutynin